US Stocks

Sio Gene Therapies Inc.

Sio Gene Therapies Inc. develops gene therapies for neurodegenerative diseases, working with companies like Oxford BioMedica and The University of Massachusetts Medical School to commercialize product candidates such as AXO-Lenti-PD and AXO-AAV-GM. Formerly known as Axovant Gene Therapies Ltd., the company changed its name in November 2020 and was founded in 2014 in New York.